<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD07630000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P51955</UniProt_ID>
  <Seq_Length>445</Seq_Length>
  <Molecule_Weight>51763</Molecule_Weight>
  <KEGG_ID>hsa:4751</KEGG_ID>
  <Orthology_ID>K08857</Orthology_ID>
  <EBI_ID>EBI-633182</EBI_ID>
  <Function_Summary>Protein kinase which is involved in the control of centrosome separation and bipolar spindle formation in mitotic cells and chromatin condensation in meiotic cells. Regulates centrosome separation (essential for the formation of bipolar spindles and high-fidelity chromosome separation) by phosphorylating centrosomal proteins such as CROCC, CEP250 and NINL, resulting in their displacement from the centrosomes. Regulates kinetochore microtubule attachment stability in mitosis via phosphorylation of NDC80. Involved in regulation of mitotic checkpoint protein complex via phosphorylation of CDC20 and MAD2L1. Plays an active role in chromatin condensation during the first meiotic division through phosphorylation of HMGA2. Phosphorylates: PPP1CC; SGOL1; NECAB3 and NPM1. Essential for localization of MAD2L1 to kinetochore and MAPK1 and NPM1 to the centrosome. Isoform 1 phosphorylates and activates NEK11 in G1/S-arrested cells. Isoform 2, which is not present in the nucleolus, does not.</Function_Summary>
  <Catalytic_Mechanism>ATP + a protein = ADP + a phosphoprotein.</Catalytic_Mechanism>
  <Pfam_ID>PF00069:Pkinase</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>HSPK 21</Alias>
      <Alias>NimA-related protein kinase 2</Alias>
      <Alias>NimA-like protein kinase 1</Alias>
      <Alias>Never in mitosis A-related kinase 2</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.</Detail>
      <Keyword>Kinase activity</Keyword>
      <Ontology_ID>GO:0016301</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein phosphatase.</Detail>
      <Keyword>Protein phosphatase binding</Keyword>
      <Ontology_ID>GO:0019903</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.</Detail>
      <Keyword>Protein serine/threonine kinase activity</Keyword>
      <Ontology_ID>GO:0004674</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>354</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>410</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the alignment of chromosomes at the metaphase plate, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.</Detail>
      <Keyword>Chromosome segregation</Keyword>
      <Ontology_ID>GO:0007059</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the attachment of spindle microtubules to the kinetochore.</Detail>
      <Keyword>Regulation of attachment of spindle microtubules to kinetochore</Keyword>
      <Ontology_ID>GO:0051988</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cell cycle process comprising the steps by which a cell progresses through the nuclear division phase of a meiotic cell cycle, the specialized nuclear and cell division in which a single diploid cell undergoes two nuclear divisions following a single round of DNA replication in order to produce four daughter cells that contain half the number of chromosomes as the diploid cell. Meiotic division occurs during the formation of gametes from diploid organisms and at the beginning of haplophase in those organisms that alternate between diploid and haploid generations.</Detail>
      <Keyword>Meiosis</Keyword>
      <Ontology_ID>GO:0007126</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A cell cycle process comprising the steps by which the nucleus of a eukaryotic cell divides; the process involves condensation of chromosomal DNA into a highly compacted form. Canonically, mitosis produces two daughter nuclei whose chromosome complement is identical to that of the mother cell.</Detail>
      <Keyword>Mitosis</Keyword>
      <Ontology_ID>GO:0007067</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which duplicated centrosome components move away from each other. The centriole pair within each centrosome becomes part of a separate microtubule organizing center that nucleates a radial array of microtubules called an aster. The two asters move to opposite sides of the nucleus to form the two poles of the mitotic spindle.</Detail>
      <Keyword>Centrosome separation</Keyword>
      <Ontology_ID>GO:0051299</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.</Detail>
      <Keyword>Cell cycle</Keyword>
      <Ontology_ID>GO:0007049</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The aggregation, arrangement and bonding together of a set of components to form the spindle, the array of microtubules and associated molecules that serves to move duplicated chromosomes apart.</Detail>
      <Keyword>Spindle assembly</Keyword>
      <Ontology_ID>GO:0051225</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process resulting in the physical partitioning and separation of a cell into daughter cells.</Detail>
      <Keyword>Cell division</Keyword>
      <Ontology_ID>GO:0051301</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the separation of duplicated centrosome components at the beginning of mitosis.</Detail>
      <Keyword>Regulation of mitotic centrosome separation</Keyword>
      <Ontology_ID>GO:0046602</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The phosphorylation by a protein of one or more of its own amino acid residues, or residues on an identical protein.</Detail>
      <Keyword>Protein autophosphorylation</Keyword>
      <Ontology_ID>GO:0046777</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Progression from G2 phase to M phase of the mitotic cell cycle.</Detail>
      <Keyword>G2/M transition of mitotic cell cycle</Keyword>
      <Ontology_ID>GO:0000086</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>387</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>170</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>438</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>179</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>299</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>241</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>175</Position>
      <PTM_Type>Phosphothreonine</PTM_Type>
    </PTM>
    <PTM>
      <Position>296</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>184</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>397</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>390</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>406</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>428</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>300</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>365</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>402</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>171</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>356</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIADLVADEQRRNLERRGRQLGEPEKSQDSSPVLSELKLKEIQLQERERALKAREERLEQKEQELCVRERLAEDKLARAENLLKNYSLLKERKFLSLASNPELLNLPSSVIKKKVHFSGESKENIMRSENSESQLTSKSKCKDLKKRLHAAQLRAQALSDIEKNYQLKSRQILGMR</Protein_Seq>
    <DNA_Seq>GCGACGGTTAAACGGGGCCCAAGGCAGGGGTGGCGGGTCAGTGCTGCTCGGGGGCTTCTCCATCCAGGTCCCTGGAGTTCCTGGTCCCTGGAGCTCCGCACTTGGCGGCGCAACCTGCGTGAGGCAGCGCGACTCTGGCGACTGGCCGGCCATGCCTTCCCGGGCTGAGGACTATGAAGTGTTGTACACCATTGGCACAGGCTCCTACGGCCGCTGCCAGAAGATCCGGAGGAAGAGTGATGGCAAGATATTAGTTTGGAAAGAACTTGACTATGGCTCCATGACAGAAGCTGAGAAACAGATGCTTGTTTCTGAAGTGAATTTGCTTCGTGAACTGAAACATCCAAACATCGTTCGTTACTATGATCGGATTATTGACCGGACCAATACAACACTGTACATTGTAATGGAATATTGTGAAGGAGGGGATCTGGCTAGTGTAATTACAAAGGGAACCAAGGAAAGGCAATACTTAGATGAAGAGTTTGTTCTTCGAGTGATGACTCAGTTGACTCTGGCCCTGAAGGAATGCCACAGACGAAGTGATGGTGGTCATACCGTATTGCATCGGGATCTGAAACCAGCCAATGTTTTCCTGGATGGCAAGCAAAACGTCAAGCTTGGAGACTTTGGGCTAGCTAGAATATTAAACCATGACACGAGTTTTGCAAAAACATTTGTTGGCACACCTTATTACATGTCTCCTGAACAAATGAATCGCATGTCCTACAATGAGAAATCAGATATCTGGTCATTGGGCTGCTTGCTGTATGAGTTATGTGCATTAATGCCTCCATTTACAGCTTTTAGCCAGAAAGAACTCGCTGGGAAAATCAGAGAAGGCAAATTCAGGCGAATTCCATACCGTTACTCTGATGAATTGAATGAAATTATTACGAGGATGTTAAACTTAAAGGATTACCATCGACCTTCTGTTGAAGAAATTCTTGAGAACCCTTTAATAGCAGATTTGGTTGCAGACGAGCAAAGAAGAAATCTTGAGAGAAGAGGGCGACAATTAGGAGAGCCAGAAAAATCGCAGGATTCCAGCCCTGTATTGAGTGAGCTGAAACTGAAGGAAATTCAGTTACAGGAGCGAGAGCGAGCTCTCAAAGCAAGAGAAGAAAGATTGGAGCAGAAAGAACAGGAGCTTTGTGTTCGTGAGAGACTAGCAGAGGACAAACTGGCTAGAGCAGAAAATCTGTTGAAGAACTACAGCTTGCTAAAGGAACGGAAGTTCCTGTCTCTGGCAAGTAATCCAGAGTCTCACTTTGTTGCCCAGGCTGGAATGCAGTGGTGTGATCACAGCTCAATGTAGCCTTGGCCTCGTAGGCTCAAGTAATCCTCCCACTTCAGCCTCCTGTGATGGAGTCTCACTGTTTTGCCCAGGATGGTCTTGAACTCATGGGCTCAAGCAATCCTCCCACCTTGGCTGGGATTACAGGTATGAGCCATTGCGCCCAGCCCCTTTATGACCTATTTCTTTATGAATATGGCTTGTCTGTTCATTACTGATATAATTATGCAACTTTCATTAGTATATATGAATGTTTATGCTTGCACAAAAATGTATGTTATTATTGCCTATTTTATTGCATAAAGTGACCTATGAAGTGTTCTGTGTTTTCATATGTTTCTCAAATAAATTCCCTTTAAAAATGTAAATACATGTAAATGTAAAAAAAAAAGTAAATAAATATCTTTTAAAGAATTTTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Primary breast tumors</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Testis</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Peripheral blood T-cells</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Kinetochore</CellLocal>
      <Ontology_ID>GO:0000776</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleolus</CellLocal>
      <Ontology_ID>GO:0005730</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoskeleton</CellLocal>
      <Ontology_ID>GO:0005856</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Spindle pole</CellLocal>
      <Ontology_ID>GO:0000922</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Chromosome</CellLocal>
      <Ontology_ID>KW-0158</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Condensed chromosome kinetochore</CellLocal>
      <Ontology_ID>GO:0000777</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Centrosome</CellLocal>
      <Ontology_ID>GO:0005813</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Microtubule</CellLocal>
      <Ontology_ID>GO:0005874</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Chromosome, centromeric region</CellLocal>
      <Ontology_ID>GO:0000775</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>NEK2</Gene_Name>
    <Gene_Alias>NEK2A; NLK1</Gene_Alias>
    <Gene_ID>4751</Gene_ID>
    <Genbank_ACCN>NM_001204182</Genbank_ACCN>
    <Protein_ACCN>NP_001191111</Protein_ACCN>
    <HGNC_ID>7745</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/4751</Gene_URL>
    <UCSC_ID>uc001his.4</UCSC_ID>
    <EMBL_ID>ENSG00000117650</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q6GQ04</Uniprot_ID>
      <Gene_Name>cdc27</Gene_Name>
      <EBI_ID>EBI-995003</EBI_ID>
      <PPI_EBI_URL>EBI-633182,EBI-995003</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P30260</Uniprot_ID>
      <Gene_Name>CDC27</Gene_Name>
      <EBI_ID>EBI-994813</EBI_ID>
      <PPI_EBI_URL>EBI-633182,EBI-994813</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q8NG66</Uniprot_ID>
      <Gene_Name>NEK11</Gene_Name>
      <EBI_ID>EBI-633195</EBI_ID>
      <PPI_EBI_URL>EBI-633182,EBI-633195</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Retinitis Pigmentosa</Disease_Name>
      <Disease_Detail>Retinitis Pigmentosa</Disease_Detail>
      <Disease_DB>RTN008</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/retinitis_pigmentosa?search=NEK2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Van Der Woude Syndrome</Disease_Name>
      <Disease_Detail>Van Der Woude Syndrome</Disease_Detail>
      <Disease_DB>VND002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/van_der_woude_syndrome?search=NEK2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Plexiform Neurofibroma</Disease_Name>
      <Disease_Detail>Plexiform Neurofibroma</Disease_Detail>
      <Disease_DB>PLX002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/plexiform_neurofibroma?search=NEK2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Retinitis Pigmentosa 67</Disease_Name>
      <Disease_Detail>Retinitis Pigmentosa</Disease_Detail>
      <Disease_DB>RTN140</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/retinitis_pigmentosa_67?search=NEK2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 2</PDB_Title>
      <PDB_ID>2XKF</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XKF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: Sar and Structural Characterization.</PubMed_Title>
      <Author>Whelligan, D.K., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:7682-7698</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20936789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO CCT242430</PDB_Title>
      <PDB_ID>2XNN</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XNN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Benzimidazole Inhibitors Induce a Dfg-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure-Activity Relationship.</PubMed_Title>
      <Author>Solanki, S., et al.</Author>
      <Journal>J.Med.Chem.(2011)54:1626-1639</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21366329?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 15</PDB_Title>
      <PDB_ID>2XK8</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XK8</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: Sar and Structural Characterization.</PubMed_Title>
      <Author>Whelligan, D.K., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:7682-7698</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20936789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 17</PDB_Title>
      <PDB_ID>2XK4</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XK4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: Sar and Structural Characterization.</PubMed_Title>
      <Author>Whelligan, D.K., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:7682-7698</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20936789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 35</PDB_Title>
      <PDB_ID>2XK3</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XK3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: Sar and Structural Characterization.</PubMed_Title>
      <Author>Whelligan, D.K., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:7682-7698</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20936789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950</PDB_Title>
      <PDB_ID>2WQO</PDB_ID>
      <Resolution>2.17</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2WQO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>An Autoinhibitory Tyrosine Motif in the Cell-Cycle- Regulated Nek7 Kinase is Released Through Binding of Nek9.</PubMed_Title>
      <Author>Richards, M.W., et al.</Author>
      <Journal>Mol.Cell(2009)36:560-570</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19941817?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 14</PDB_Title>
      <PDB_ID>2XKC</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XKC</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: Sar and Structural Characterization.</PubMed_Title>
      <Author>Whelligan, D.K., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:7682-7698</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20936789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 36</PDB_Title>
      <PDB_ID>2XK6</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XK6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: Sar and Structural Characterization.</PubMed_Title>
      <Author>Whelligan, D.K., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:7682-7698</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20936789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO CCT</PDB_Title>
      <PDB_ID>2XNM</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XNM</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Benzimidazole Inhibitors Induce a Dfg-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure-Activity Relationship.</PubMed_Title>
      <Author>Solanki, S., et al.</Author>
      <Journal>J.Med.Chem.(2011)54:1626-1639</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21366329?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO CCT243779</PDB_Title>
      <PDB_ID>2XNO</PDB_ID>
      <Resolution>1.98</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XNO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Benzimidazole Inhibitors Induce a Dfg-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure-Activity Relationship.</PubMed_Title>
      <Author>Solanki, S., et al.</Author>
      <Journal>J.Med.Chem.(2011)54:1626-1639</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21366329?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN KINASE WITH PYRROLE-INDOLINONE LIGAND</PDB_Title>
      <PDB_ID>2JAV</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2JAV</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure and Regulation of the Human Nek2 Centrosomal Kinase</PubMed_Title>
      <Author>Rellos, P., et al.</Author>
      <Journal>J.Biol.Chem.(2007)282:6833</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17197699?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO AMINIPYRAZINE COMPOUND 5</PDB_Title>
      <PDB_ID>2XKE</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XKE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: Sar and Structural Characterization.</PubMed_Title>
      <Author>Whelligan, D.K., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:7682-7698</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20936789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN NEK2 KINASE APO</PDB_Title>
      <PDB_ID>2W5H</PDB_ID>
      <Resolution>2.33</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2W5H</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Insights Into the Conformational Variability and Regulation of Human Nek2 Kinase.</PubMed_Title>
      <Author>Westwood, I., et al.</Author>
      <Journal>J.Mol.Biol.(2009)386:476-485</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19124027?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 12</PDB_Title>
      <PDB_ID>2XKD</PDB_ID>
      <Resolution>1.96</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XKD</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: Sar and Structural Characterization.</PubMed_Title>
      <Author>Whelligan, D.K., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:7682-7698</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20936789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN NEK2 KINASE ADP-BOUND</PDB_Title>
      <PDB_ID>2W5A</PDB_ID>
      <Resolution>1.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2W5A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Insights Into the Conformational Variability and Regulation of Human Nek2 Kinase.</PubMed_Title>
      <Author>Westwood, I., et al.</Author>
      <Journal>J.Mol.Biol.(2009)386:476</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19124027?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 23</PDB_Title>
      <PDB_ID>2XK7</PDB_ID>
      <Resolution>1.99</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XK7</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: Sar and Structural Characterization.</PubMed_Title>
      <Author>Whelligan, D.K., et al.</Author>
      <Journal>J.Med.Chem.(2010)53:7682-7698</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20936789?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>STRUCTURE OF NEK2 BOUND TO CCT244858</PDB_Title>
      <PDB_ID>2XNP</PDB_ID>
      <Resolution>1.98</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XNP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Benzimidazole Inhibitors Induce a Dfg-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure-Activity Relationship.</PubMed_Title>
      <Author>Solanki, S., et al.</Author>
      <Journal>J.Med.Chem.(2011)54:1626-1639</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21366329?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN NEK2 KINASE ATPGAMMAS-BOUND</PDB_Title>
      <PDB_ID>2W5B</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2W5B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Insights Into the Conformational Variability and Regulation of Human Nek2 Kinase.</PubMed_Title>
      <Author>Westwood, I., et al.</Author>
      <Journal>J.Mol.Biol.(2009)386:476-485</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19124027?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.daa.b.b.hc.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/2jav</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Dimerization</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.7.11.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/7/11/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>